Chiabotti, P. S., Rouaud, O., & Allali, G. (2024). Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging. Neurology, 102, . https://doi.org/10.1212/wnl.0000000000209375
Chicago Style (17th ed.) CitationChiabotti, Paolo Salvioni, Olivier Rouaud, and Gilles Allali. "Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging." Neurology 102 (2024). https://doi.org/10.1212/wnl.0000000000209375.
MLA (9th ed.) CitationChiabotti, Paolo Salvioni, et al. "Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging." Neurology, vol. 102, 2024, https://doi.org/10.1212/wnl.0000000000209375.
Warning: These citations may not always be 100% accurate.